StockData
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW

Apollomics Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$22.05+0.95 (+4.49%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Apollomics Inc. revenue by segment

No segment breakdown reported

Apollomics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.